The Hydropothecary Corporation (TSXV:THCX) announced the release of their Elixir CBD Peppermint cannabis oil mist product.
As quoted in the press release:
“Hydropothecary is committed to developing innovative medical cannabis products in response to our clients’ daily living needs. Our award-winning Elixir THC Peppermint product was created for people seeking an easy-to-use, discreet cannabis product suited to their busy lifestyles. With Elixir CBD Peppermint, we are responding to clients also looking for convenient and easy to use ways to consume CBD,” said Mr. Guy DeGrace, Hydropothercary’s Community Engagement Manager for Quebec and Eastern Canada.
With less than 4 mg/ml of THC and between 50 to 60 mg/ml of CBD, Elixir CBD Peppermint delivers the therapeutic benefits of CBD to patients while minimizing the psychoactive effects of THC.